TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
2018 · Neuron · 786 citations
https://doi.org/10.1016/j.neuron.2018.01.031
N
Ningyan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
268
Papers
8.7K
Citations
49
h-index
109
i10-index
Ningyan Zhang is an academic researcher from Kunming Medical University. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HER2/EGFR in Cancer Research & Immune Cell Function and Interaction. The author has an h-index of 49, co-authored 228 publications.
ORCID: 0000-0002-4348-2180Papers by this author
worksLILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
2018 · Nature · 284 citations
https://doi.org/10.1038/s41586-018-0615-z
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
2021 · Nature Communications · 269 citations
https://doi.org/10.1038/s41467-021-23793-7
Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
2015 · The Journal of Immunology · 187 citations
https://doi.org/10.4049/jimmunol.1402891
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
2011 · mAbs · 93 citations
https://doi.org/10.4161/mabs.3.3.15532
Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency
2017 · Organic & Biomolecular Chemistry · 89 citations
https://doi.org/10.1039/c7ob01027c
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat